Home
  >  
Section 56
  >  
Chapter 55,133

Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers

Chu, Y.; Li, D.; Luo, Y.-F.; He, X.-J.; Jiang, M.-Y.

Molecules 19(2): 2445-2457

2014


ISSN/ISBN: 1420-3049
PMID: 24566313
DOI: 10.3390/molecules19022445
Accession: 055132804

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Curcumin, a phenolic antioxidant compound derived from the rhizome of the turmeric plant Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion and apoptosis, revealing its anticancer potential. In this study, a Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carrier (Cur-GA-PEG-NLC) was prepared by the film ultrasound method to improve the tumor-targeting ability. The drug content was detected by an UV spectrophotometry method. The encapsulation efficiency of curcumin in the nanostructured lipid carriers (NLCs) was determined using a mini-column centrifugation method. The encapsulation efficiency for various Cur-GA-PEG-NLC was within the range of 90.06%-95.31% and particle size was between 123.1 nm and 132.7 nm. An in vitro MTT assay showed that Cur-GA10%-PEG-NLC had significantly high cellular uptake and cytotoxicity against HepG2 cells compared with other groups.

PDF emailed within 0-6 h: $19.90